Macular degeneration drug approval is a significant milestone for Olix, enhancing its global licensing strategy.
drug approval
Vamorolone South Korea approval: A Smart Move for Nxera
Vamorolone South Korea approval is a significant step for Nxera Pharma in treating Duchenne muscular dystrophy.
Export NOC for r-DNA drugs: Is it the Best Move?
Export NOC for r-DNA drugs is a significant change in regulations that could benefit the pharmaceutical industry.